News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,760 Results
Type
Article (508)
Company Profile (2)
Press Release (8250)
Section
Business (1744)
Career Advice (20)
Deals (302)
Drug Development (2099)
Employer Resources (1)
FDA (470)
Job Trends (446)
News (4718)
Policy (630)
Tag
Academia (21)
Accelerated approval (2)
Adcomms (1)
Allergies (19)
Alliances (455)
ALS (1)
Alzheimer's disease (15)
Antibody-drug conjugate (ADC) (19)
Approvals (506)
Artificial intelligence (5)
Bankruptcy (1)
Best Places to Work (463)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (3)
Brain cancer (4)
Breast cancer (39)
Cancer (267)
Cardiovascular disease (7)
Career advice (14)
CAR-T (3)
Cell therapy (6)
Clinical research (1964)
Collaboration (23)
Compensation (2)
COVID-19 (18)
C-suite (10)
Cystic fibrosis (5)
Data (200)
Diabetes (4)
Diagnostics (54)
Drug discovery (5)
Drug pricing (2)
Duchenne muscular dystrophy (1)
Earnings (875)
Employer resources (1)
Events (1438)
Executive appointments (15)
FDA (579)
Fibrodysplasia Ossificans Progressiva (1)
Funding (15)
Gene therapy (4)
GLP-1 (8)
Government (89)
Grass and pollen (3)
Guidances (10)
Healthcare (175)
Immunology and inflammation (2)
Immuno-oncology (1)
Indications (9)
Infectious disease (23)
Inflation Reduction Act (1)
Influenza (1)
Intellectual property (4)
Interviews (5)
IPO (165)
Job creations (17)
Job search strategy (12)
Layoffs (4)
Legal (44)
Liver cancer (3)
Lung cancer (90)
Lymphoma (24)
Management (1)
Manufacturing (2)
MASH (7)
Medical device (31)
Medtech (31)
Mergers & acquisitions (144)
Metabolic disorders (21)
Multiple sclerosis (6)
Neurodegenerative disease (1)
Neuroscience (28)
NextGen: Class of 2026 (42)
Non-profit (33)
Obesity (8)
Opinion (3)
Ovarian cancer (11)
Pain (1)
Pancreatic cancer (6)
Parkinson's disease (2)
Patents (7)
Patient recruitment (4)
Peanut (4)
People (474)
Pharmaceutical (2)
Phase 1 (439)
Phase 2 (740)
Phase 3 (964)
Pipeline (119)
Policy (3)
Postmarket research (84)
Preclinical (138)
Press Release (1)
Prostate cancer (6)
Psychedelics (1)
Radiopharmaceuticals (3)
Rare diseases (21)
Real estate (26)
Regulatory (646)
Research institute (27)
Resumes & cover letters (4)
RSV (2)
Series A (4)
Series B (3)
Special edition (1)
Spinal muscular atrophy (2)
Startups (32)
Stomach cancer (1)
Supply chain (1)
The Weekly (2)
Vaccines (7)
Venture capital (3)
Weight loss (3)
Date
Last 7 days (13)
Last 30 days (40)
Last 365 days (549)
2026 (52)
2025 (556)
2024 (660)
2023 (696)
2022 (812)
2021 (911)
2020 (768)
2019 (605)
2018 (534)
2017 (460)
2016 (415)
2015 (488)
2014 (284)
2013 (190)
2012 (187)
2011 (202)
2010 (182)
Location
Africa (2)
Arizona (1)
Asia (653)
Australia (44)
California (145)
Canada (62)
China (42)
Connecticut (3)
Delaware (33)
Europe (1500)
Florida (8)
Georgia (19)
Illinois (56)
India (2)
Indiana (14)
Japan (32)
Kentucky (2)
Maryland (46)
Massachusetts (131)
Michigan (2)
Missouri (1)
Nevada (1)
New Jersey (123)
New Mexico (1)
New York (61)
North Carolina (6)
Northern California (63)
Ohio (1)
Pennsylvania (20)
South America (2)
Southern California (56)
Texas (11)
United States (722)
Utah (1)
Washington State (47)
8,760 Results for "alk".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ALK – Financial calendar for the 2026 financial year
December 23, 2025
·
1 min read
Press Releases
ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children
January 30, 2026
·
2 min read
Press Releases
ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
January 9, 2026
·
1 min read
Press Releases
Invitation to the presentation of ALK’s first nine months (Q3) 2025 results on Thursday, 13 November 2025
November 7, 2025
·
1 min read
Press Releases
ALK upgrades its 2025 full-year outlook
November 13, 2025
·
1 min read
Press Releases
ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America
December 2, 2025
·
2 min read
Press Releases
ALK and GenSci partner to expand the AIT market in China
September 17, 2025
·
5 min read
Press Releases
Invitation to the presentation of ALK’s first six months (Q2) 2025 results on Thursday, 21 August 2025
August 15, 2025
·
1 min read
Press Releases
ALK’s tree pollen tablet (ITULAZAX®) now recommended by NICE for use in the UK health system
July 21, 2025
·
2 min read
Press Releases
ALK expands the Executive Leadership Team to include key commercial regions
September 4, 2025
·
3 min read
1 of 876
Next
